BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2502615)

  • 21. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
    Morley PA; Munot LD
    Curr Med Res Opin; 1988; 11(2):142-8. PubMed ID: 3146465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonic acid, a new antibiotic for topical therapy.
    Wuite J; Davies BI; Go MJ; Lambers JC; Jackson D; Mellows G; Tasker TC
    J Am Acad Dermatol; 1985 Jun; 12(6):1026-31. PubMed ID: 3924981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of mupirocin (pseudomonic acid) in the treatment of pyoderma in children.
    Phillips LM; Yogev R; Esterly NB
    Pediatr Emerg Care; 1985 Dec; 1(4):180-3. PubMed ID: 3939498
    [No Abstract]   [Full Text] [Related]  

  • 24. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
    McLinn S
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of mupirocin ointment in the treatment of impetigo.
    Leyden JJ
    Clin Pediatr (Phila); 1992 Sep; 31(9):549-53. PubMed ID: 1468173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
    White DG; Collins PO; Rowsell RB
    J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How resistant is Staphylococcus aureus to the topical antibiotic mupirocin?
    Rakshit T; Shenoy M S
    J Glob Antimicrob Resist; 2017 Mar; 8():102-103. PubMed ID: 28082145
    [No Abstract]   [Full Text] [Related]  

  • 28. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Campoli-Richards DM
    Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1987 Jan; 19(1):1-5. PubMed ID: 3104272
    [No Abstract]   [Full Text] [Related]  

  • 30. Mupirocin vs terbinafine in impetigo.
    Ciftci E; Guriz H; Aysev AD
    Indian J Pediatr; 2002 Aug; 69(8):679-82. PubMed ID: 12356219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impetigo: A need for new therapies in a world of increasing antimicrobial resistance.
    D'Cunha NM; Peterson GM; Baby KE; Thomas J
    J Clin Pharm Ther; 2018 Feb; 43(1):150-153. PubMed ID: 29063621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mupirocin: a new topical antibiotic.
    Leyden JJ
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
    Gilbert M
    J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
    Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
    J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical inquiry: what is the best treatment for impetigo ?
    Shim J; Lanier J; Qui MK
    J Fam Pract; 2014 Jun; 63(6):333-5. PubMed ID: 25061625
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of impetigo: save mupirocin.
    Axelsson I
    BMJ; 2004 Oct; 329(7472):979. PubMed ID: 15499129
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
    Bork K; Brauers J; Kresken M
    Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis of treatments for impetigo.
    George A; Rubin G
    Br J Gen Pract; 2003 Jun; 53(491):480-7. PubMed ID: 12939895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative review of current topical antibiotics for impetigo.
    Galindo E; Hebert AA
    Expert Opin Drug Saf; 2021 Jun; 20(6):677-683. PubMed ID: 33726585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.